Produkty 118627-52-4

CAS 118627-52-4 występuje w naszej ofercie pod nazwami: Epivogeloside, epi-Vogeloside, Epivogeloside, ≥98%. Oferty producentów: GLPBio, Biosynth, MedChemExpress, Chemat. Dostępne opakowania: 5mg, 10mg, 25mg, 50mg, 5 mg, 1 mg.

Epivogeloside
GLPBio, Biosynth
  • opakowanie: 5mg, 10mg, 25mg, 50mg
  • Warianty: 5
od 5066,92
Zobacz produkt
epi-Vogeloside
MedChemExpress
  • opakowanie: 5 mg, 1 mg
  • Warianty: 2
od 2567,39
Zobacz produkt
Epivogeloside, ≥98%
Chemat
  • opakowanie: 5mg
  • Warianty: 1
od 3611,60
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,4aS,5R,6S)-5-ethenyl-3-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one (CAS 118627-52-4) to związek chemiczny o wzorze sumarycznym C17H24O10 i masie molowej 388.4 g/mol. Nazwa systematyczna IUPAC: (3S,4aS,5R,6S)-5-ethenyl-3-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one. InChIKey: RAYZRCGMIDUTKS-RJFLBQOQSA-N.

Dane identyfikacyjne
Wzór sumarycznyC17H24O10
Masa molowa388.4 g/mol
Nazwa IUPAC(3S,4aS,5R,6S)-5-ethenyl-3-methoxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one
InChIKeyRAYZRCGMIDUTKS-RJFLBQOQSA-N
SMILESCO[C@@H]1C[C@H]2[C@H]([C@@H](OC=C2C(=O)O1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C=C

Dane obliczone przez PubChem (NCBI)

Synonimy: Epivogeloside, epi-Vogeloside, Nervoside, 7-epi-Vogeloside; Epivogeloside; Isovogeloside; Nervoside, orb1684623
Powiązane formy tego związku
5-ethenyl-3-methoxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one C17H24O10
Izomery (ten sam wzór sumaryczny)
[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-prop-2-enoxyoxan-2-yl]methyl acetate C17H24O10
[(2R,3R,4S,5R,6S)-3,5,6-triacetyloxy-4-prop-2-enoxyoxan-2-yl]methyl acetate C17H24O10
methyl (1S,4aS,7aS)-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate C17H24O10
methyl (1S,4aS,7S,7aR)-7-methyl-5-oxo-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,6,7,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate C17H24O10
[(2R,3R,4S,5S,6S)-3,4,5-triacetyloxy-6-prop-2-enoxyoxan-2-yl]methyl acetate C17H24O10
methyl (2S,3R,4S)-3-ethenyl-4-(2-oxoethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylate C17H24O10
[(3aS,5R,6R,7S,7aS)-6,7-diacetyloxy-2-methyl-2-prop-2-enoxy-5,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-b]pyran-5-yl]methyl acetate C17H24O10
methyl 7-(hydroxymethyl)-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate C17H24O10
methyl 7-methyl-6-oxo-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,7,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate C17H24O10
2-(hydroxymethyl)-6-[4-[3-(hydroxymethyl)oxiran-2-yl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol C17H24O10